Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The use of data, evidence and digital tools in healthcare and policy takes a major stride forward with the official launch of the Bennett Institute for Applied Data Science and appointment of Ben Goldacre as Bennett Professor of Evidence-Based Medicine

Lines of numbers overlaying people to represent big data science

Named in recognition of a generous donation from the Peter Bennett Foundation, the new Bennett Institute is based within the Nuffield Department of Primary Care Health Sciences at the University of Oxford.

The Bennett Institute builds on a foundation of world-leading healthcare data science from the DataLab at the University of Oxford. It brings together a diverse group of academics from a range of disciplines, including clinicians, software engineers, policy experts and statisticians. Together, as the Bennett Institute, they will develop, use and evidence new tools and methods that will ensure data and evidence can have impact in the world, improving the lives of patients and citizens.

The newly appointed ‘Bennett Professor of Evidence-Based Medicine’, Professor Ben Goldacre, is also the inaugural director of the Bennett Institute.

Read the full story on the Nuffield Department of Primary Care Health Sciences website

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.